Clinical Trials Browser

Phase 2 × Lymphoma, Non-Hodgkin × Interleukin-2 × Clear all

NCT00994643 2025-04-30

Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma

Phase 2 Completed

11 enrolled 9 charts

Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin

NCT01181258 2018-02-06

MT2009-15

Phase 2 Completed

16 enrolled 8 charts

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02259348 2017-05-30

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

Phase 2 Terminated

12 enrolled 12 charts

LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT00001430 2008-03-04

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

Phase 2 Completed

49 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT00100737 2006-02-06

Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)

Phase 2 Terminated

300 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin